4-5 February, 2020 LSX World Congress London, UK Team members attending: Dr Giuseppe Mazza, CEO [panel speaker]
This author has yet to write their bio.Meanwhile lets just say that we are proud primitus contributed a whooping 21 entries.
Entries by primitus
13-16 January 2020 Biotech Showcase / J.P. Morgan Healthcare Conference San Francisco, USA Team members attending: Dr Giuseppe Mazza, CEO, David Dally, CFO
January 2020 Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition Mazza. G, Telese. A, Al-Akkad. W, Frenguelli. L, Levi. A, Marrali. M, Longato. L, Thanapirom. K, Vilia. M.G, Lombardi. B, Crowley. C, Crawford. M, Karsdal. M.A, Leeming. D.J, Marrone. G, Bottcher. K, Robinson. B, Del Rio Hernandez. A, Tamburrino. D, […]
London, UK and Waltham, Massachusetts, USA – 10 December, 2019 – Engitix Ltd (‘Engitix’), a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, and Morphic Therapeutic (‘Morphic’), a biopharmaceutical company developing oral integrin therapies, today announce that they have entered into a research […]
20-21 November 2019 Jefferies 2019 London Healthcare Conference London, UK Team members attending: Dr Giuseppe Mazza, CEO, David Dally, CFO, Stephen Brindle, COO
8-12 November 2019 70th Annual Meeting of the American Association for The Study of Liver Diseases (AASLD) Boston, USA Team members attending: Dr Giuseppe Mazza, CEO, Dr Gino Van Heeke, CSO, Massimo Pinzani
Golden Ticket includes one year of lab bench space at Cambridge, MA-based shared laboratory and office space London, UK, 5 November 2019 – Engitix Ltd (‘Engitix’), a private company focused on drug discovery for fibrosis and solid tumours based on its pioneering human extracellular matrix (ECM) platform, announced that its subsidiary Engitix, Inc, has been awarded a Golden Ticket […]
November 2019 Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis Simón Serrano. S, Grönberg. A, Longato. L, Rombouts. K, Kuo. J, Gregory. M, Moss. S, Elmér. E, Mazza. G, Gallay. P, Pinzani. M, Hansson. M.J, Massoumi. R. Cells. 8(11):1409.
October 2019 Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis Giuffrida. P, Curti. P, Al-Akkad. W, Biel. C, Crowley. C, Frenguelli. L, Telese. A, Hall. A, Tamburrino. D, Spolentini. G, Fusai. G, Tinozzi. FP, Pietrabissa. A, Corazza. GR, De Coppi. P, Pinzani. M, Di Sabatino. A, Rombouts. K, Mazza. G. […]
August 2019 Decellularized human liver scaffold-based three-dimensional culture system facilitate hepatitis B virus infection Zhang. Z, Xu. H, Mazza. G, Zhang. M, Frenguelli. L, Liu. Q, Al-Akkad. W, Ren. J, Zhao. R, Ren. F, Chen. X, Huang. A, Chen. J. Journal of Biomedical Materials Research Part A. 107(8):1744-1753.